GDF15 and type 2 diabetes mellitus: Anti-inflammatory drugs such as the nonsteroidal anti-inflammatory drugs (NSAID) can induce GDF15 expression [13], and VLDC can significantly reduce low-grade inflammation of type 2 diabetes mellitus patients [42].